Cyclerion Therapeutics Inc. (CYCN) at a glance

Cyclerion Therapeutics Inc. (CYCN) is a micro-cap Healthcare company. It trades at $3.2, with a -264.7% profit margin and revenue decline of 100%. It does not pay a dividend. Vestovix scores it 34/100 overall. Its strongest dimension is Safety (44/100) and its weakest is Growth (12/100). It carries above-market volatility, so expect larger swings.

Price

$3.20

Market cap

$14.1M

P/E ratio

n/a

Dividend yield

None

Beta

1.77

52-week range

$1.03 to $8.48